12:27 PM
 | 
Oct 20, 2017
 |  BC Week In Review  |  Company News  |  Deals

Allcyte and Boehringer to characterize cancer compounds

Last month, Allcyte said it partnered with Boehringer Ingelheim GmbH (Ingelheim, Germany) to use Allcyte's Pharmacoscopy ex vivo...

Read the full 68 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >